Bob Siegerink Selected Research

Leukocytosis (Pleocytosis)

1/2016

Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bob Siegerink Research Topics

Disease

17	Ischemic Stroke 10/2022 - 11/2009
16	Stroke (Strokes) 10/2022 - 10/2015
7	Thrombosis (Thrombus) 01/2018 - 11/2009
6	Myocardial Infarction 01/2017 - 08/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2013
3	Venous Thrombosis (Deep-Vein Thrombosis) 07/2017 - 07/2013
2	Cerebral Hemorrhage 10/2020 - 04/2016
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Critical Illness (Critically Ill) 10/2020
1	Sepsis (Septicemia) 10/2020
1	Pneumonia (Pneumonitis) 10/2020
1	Atrial Fibrillation 01/2020
1	Dementia (Dementias) 01/2019
1	Out-of-Hospital Cardiac Arrest 01/2018
1	Perinatal Death 12/2017
1	Embolism (Embolus) 06/2017
1	Peripheral Arterial Occlusive Disease 1 01/2017
1	Stillbirth 01/2016
1	Edema (Dropsy) 01/2016
1	Spontaneous Abortion (Miscarriage) 01/2016
1	Leukocytosis (Pleocytosis) 01/2016
1	Thrombophilia 01/2015
1	Obesity 07/2013
1	Coronary Disease (Coronary Heart Disease) 03/2013
1	ST Elevation Myocardial Infarction 05/2011
1	Inflammation (Inflammations) 05/2011
1	Hypertension (High Blood Pressure) 11/2009
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2009

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 10/2022 - 11/2009
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2017
4	Oral ContraceptivesIBA 01/2016 - 11/2009
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2022 - 11/2019
3	Troponin T (Troponin T1)IBA 01/2021 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2020 - 04/2016
3	TroponinIBA 01/2020 - 01/2019
2	Immunoglobulin A (IgA)IBA 10/2022 - 11/2019
2	Immunoglobulin G (IgG)IBA 10/2022 - 11/2019
2	Immunoglobulin M (IgM)IBA 10/2022 - 11/2019
2	fibrin fragment D (D-dimer)IBA 01/2021 - 10/2016
2	Hemostatics (Antihemorrhagics)IBA 01/2021 - 01/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 12/2020 - 01/2015
2	N-Methylaspartate (NMDA)IBA 01/2020 - 11/2019
2	Antiphospholipid AntibodiesIBA 01/2016 - 11/2009
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	SugarsIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Plasminogen Activator Inhibitor 1IBA 01/2021
1	SmokeIBA 01/2021
1	Factor XII (Hageman Factor)IBA 12/2020
1	trans-crotonin (CTN)IBA 01/2020
1	Neuroprotective AgentsIBA 11/2019
1	Protein CIBA 01/2018
1	insulin receptor-related receptor (IRR)IBA 12/2017
1	RNA (Ribonucleic Acid)IBA 06/2017
1	Indicators and Reagents (Reagents)IBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Lipoprotein(a)IBA 10/2015
1	Lipoproteins (Lipoprotein)IBA 10/2015
1	Biological ProductsIBA 07/2013
1	symmetric dimethylarginineIBA 03/2013
1	AntigensIBA 02/2012
1	Sirolimus (Rapamycin)FDA Link 05/2011
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2009
1	Factor XIII (Coagulation Factor XIII)IBA 08/2009

Therapy/Procedure

3	Thrombectomy 01/2021 - 01/2020
1	Time-to-Treatment 01/2021
1	Critical Care (Surgical Intensive Care) 10/2020
1	Defibrillators (Defibrillator) 01/2018
1	Stents 05/2011